ArticleClinical rheumatology2023

Omicron variant dominance and anti-SARS-CoV-2 vaccination are key determinants for a milder course of COVID-19 in patients with systemic autoimmune rheumatic diseases.

Charalampos Papagoras et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.